7 completed. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
Follow COMPASS Pathways: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study Psilocybin - Anorexia Nervosa | Phase 2 | Completed | COMPASS Pathways | 32 | 2022-10-12 | 2024-12-04 |
| The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder Psilocybin - Post Traumatic Stress Disorder | Phase 2 | Completed | COMPASS Pathways | 22 | 2022-06-10 | 2025-06-13 |
| The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation Psilocybin - Treatment Resistant Depression, Suicidal Ideation | Phase 2 | Completed | Sheppard Pratt Health System | 20 | 2022-03-28 | 2025-12-24 |
| Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy Psilocybin - Anorexia Nervosa | Phase 2 | Completed | University of California, San Diego | 16 | 2021-05-01 | 2022-07-25 |
| Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Psilocybin - Body Dysmorphic Disorders | Phase 2 | Completed | New York State Psychiatric Institute | 12 | 2021-02-26 | 2023-03-13 |
| The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression Psilocybin - Treatment Resistant Depression | Phase 2 | Completed | COMPASS Pathways | 19 | 2020-08-10 | 2023-11-09 |
| The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression Psilocybin - Treatment Resistant Depression | Phase 2 | Completed | COMPASS Pathways | 233 | 2019-03-01 | 2023-04-24 |
Depressive Disorder, Treatment-Resistant (3) · Anorexia Nervosa (2) · Anorexia (1) · Body Dysmorphic Disorders (1) · Depressive Disorder, Major (1) · Feeding and Eating Disorders (1) · Mental Disorders (1) · Stress Disorders, Post-Traumatic (1) · Suicidal Ideation (1)
Psilocybin (7)
United States (7) · Ireland (3) · United Kingdom (3) · Canada (1) · Czechia (1) · Denmark (1) · Germany (1) · Netherlands (1) · Portugal (1) · Spain (1)
Franklin Schneier, MD (1) · Guy Goodwin (1) · Scott Aaronson, MD (1)
PMID 31543078, PMID 36322843, PMID 37488291, PMID 38988455, PMID 40458078, PMID 40883964, PMID 41362124, PMID 41497513, PMID 41881122, PMID 42138588, PMID 42460632